To test if targeting of the stem domain to CCR1/3/5 could lead to more efficient protection against influenza, we constructed a vaccine where the MHCII-specific targeting unit was replaced with MIP1α (MIP1α-H1stem). This evidence concerns the gene CCR1 and influenza.